(Q36387783)

13 August 2017

1 reference

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Tuberous sclerosis complex: molecular pathogenesis and animal models (English)

1 reference

13 August 2017

0 references

1 reference

1 reference

Leandro R Piedimonte

1

1 reference

13 August 2017

Ian K Wailes

series ordinal

2

1 reference

13 August 2017

Howard L Weiner

series ordinal

3

1 reference

13 August 2017

publication date

15 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

20

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

E4

1 reference

Congenital subependymal giant-cell astrocytoma: case report with prenatal ultrasonogram

13 August 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Genetic control of cell size

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Aspects of tuberous sclerosis complex (TSC) protein function in the brain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Rat genetics: attaching physiology and pharmacology to the genome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Drosophila Rheb GTPase is required for cell cycle progression and cell growth

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Tuberous sclerosis: from tubers to mTOR.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Rheb promotes cell growth as a component of the insulin/TOR signalling network

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Rheb is an essential regulator of S6K in controlling cell growth in Drosophila

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Farnesyl transferase inhibitors as anticancer agents

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Infantile spasms in tuberous sclerosis complex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Neuropathology of tuberous sclerosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Insights into cancer from transgenic mouse models

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Akt regulates growth by directly phosphorylating Tsc2

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Molecular genetic advances in tuberous sclerosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Two loci for tuberous sclerosis: one on 9q34 and one on 16p13.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

The TSC1 gene product, hamartin, negatively regulates cell proliferation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Neurological manifestations of tuberous sclerosis complex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Markers of cellular proliferation are expressed in cortical tubers

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Identification and characterization of the tuberous sclerosis gene on chromosome 16

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

A role of the tuberous sclerosis gene-2 product during neuronal differentiation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.3171/FOC.2006.20.1.5

Identifiers

DOI

10.3171/FOC.2006.20.1.5

1 reference

13 August 2017

1 reference